Versigent Ltd 8-K

What Happened

• Versigent Limited (to be renamed Versigent PLC) filed an 8-K on March 12, 2026 disclosing that the SEC declared its Form 10 registration statement effective. The Form 10 relates to the planned spin-off of Versigent by parent company Aptiv PLC.
• Aptiv will distribute Versigent ordinary shares pro rata to Aptiv shareholders: holders of Aptiv ordinary shares on the record date of March 17, 2026 will receive one Versigent share for every three Aptiv shares held. The spin-off is expected to be effective at 12:01 a.m. New York City time on April 1, 2026. Versigent ordinary shares are expected to trade on the NYSE under the ticker "VGNT" on April 1, 2026 (a when-issued market may develop about three trading days earlier).
• The Information Statement dated March 12, 2026 is attached as Exhibit 99.1 and Aptiv has begun mailing that statement to its shareholders.

Key Details

• Form 10 initially filed November 14, 2025; declared effective by the SEC on March 12, 2026.
• Record Date for distribution: March 17, 2026.
• Expected Distribution Date / first regular-way trading day: April 1, 2026 (shares to trade as "VGNT").
• Exchange conversion: Versigent will convert to a public limited company and be renamed Versigent PLC prior to the spin-off.

Why It Matters

• For Aptiv shareholders: you may receive newly issued Versigent shares automatically if you held Aptiv ordinary shares on March 17, 2026 (one Versigent share per three Aptiv shares), which will create a new publicly traded security to monitor (VGNT).
• For prospective investors: the effective Form 10 and Information Statement provide key details about Versigent’s business, management and risks; review those documents (and the Form 10 risk factors) before trading. Expect limited when-issued trading shortly before April 1 and regular-way trading beginning April 1, 2026.